Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 4
2006 12
2007 12
2008 17
2009 18
2010 17
2011 15
2012 23
2013 39
2014 38
2015 39
2016 21
2017 26
2018 52
2019 27
2020 57
2021 9
2022 23
2023 23
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

398 results

Results by year

Filters applied: . Clear all
Page 1
PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors.
Plage H, Furlano K, Hofbauer S, Weinberger S, Ralla B, Franz A, Fendler A, de Martino M, Roßner F, Elezkurtaj S, Kluth M, Lennartz M, Blessin NC, Marx AH, Samtleben H, Fisch M, Rink M, Slojewski M, Kaczmarek K, Ecke T, Hallmann S, Koch S, Adamini N, Zecha H, Minner S, Simon R, Sauter G, Weischenfeldt J, Klatte T, Schlomm T, Horst D, Schallenberg S. Plage H, et al. Among authors: schlomm t. BMC Urol. 2024 Apr 24;24(1):96. doi: 10.1186/s12894-024-01482-z. BMC Urol. 2024. PMID: 38658905 Free PMC article.
Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial Cancer.
Debatin NF, Bady E, Mandelkow T, Huang Z, Lurati MCJ, Raedler JB, Müller JH, Vettorazzi E, Plage H, Samtleben H, Klatte T, Hofbauer S, Elezkurtaj S, Furlano K, Weinberger S, Giacomo Bruch P, Horst D, Roßner F, Schallenberg S, Marx AH, Fisch M, Rink M, Slojewski M, Kaczmarek K, Ecke TH, Hallmann S, Koch S, Adamini N, Lennartz M, Minner S, Simon R, Sauter G, Zecha H, Schlomm T, Blessin NC. Debatin NF, et al. Among authors: schlomm t. Eur Urol. 2024 Feb 20:S0302-2838(24)00065-4. doi: 10.1016/j.eururo.2024.01.023. Online ahead of print. Eur Urol. 2024. PMID: 38383257 Free article.
Loss of TROP2 and epithelial cell adhesion molecule expression is linked to grade progression in pTa but unrelated to disease outcome in pT2-4 urothelial bladder carcinomas.
Müller JH, Plage H, Elezkurtaj S, Mandelkow T, Huang Z, Lurati MCJ, Raedler JB, Debatin NF, Vettorazzi E, Samtleben H, Hofbauer S, Furlano K, Neymeyer J, Goranova I, Ralla B, Weinberger S, Horst D, Roßner F, Schallenberg S, Marx AH, Fisch M, Rink M, Slojewski M, Kaczmarek K, Ecke T, Hallmann S, Koch S, Adamini N, Lennartz M, Minner S, Simon R, Sauter G, Zecha H, Schlomm T, Bady E. Müller JH, et al. Among authors: schlomm t. Front Oncol. 2024 Jan 12;13:1342367. doi: 10.3389/fonc.2023.1342367. eCollection 2023. Front Oncol. 2024. PMID: 38282671 Free PMC article.
Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumors.
Schallenberg S, Plage H, Hofbauer S, Furlano K, Weinberger S, Bruch PG, Roßner F, Elezkurtaj S, Kluth M, Lennartz M, Blessin NC, Marx AH, Samtleben H, Fisch M, Rink M, Slojewski M, Kaczmarek K, Ecke T, Hallmann S, Koch S, Adamini N, Minner S, Simon R, Sauter G, Horst D, Klatte T, Schlomm T, Zecha H. Schallenberg S, et al. Among authors: schlomm t. Acta Oncol. 2023 Dec;62(12):1880-1889. doi: 10.1080/0284186X.2023.2277344. Epub 2023 Nov 25. Acta Oncol. 2023. PMID: 37938166
Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder.
Kaczmarek K, Plage H, Furlano K, Hofbauer S, Weinberger S, Ralla B, Franz A, Fendler A, de Martino M, Roßner F, Schallenberg S, Elezkurtaj S, Kluth M, Lennartz M, Blessin NC, Marx AH, Samtleben H, Fisch M, Rink M, Slojewski M, Ecke T, Hallmann S, Koch S, Adamini N, Minner S, Simon R, Sauter G, Weischenfeldt J, Klatte T, Schlomm T, Horst D, Zecha H. Kaczmarek K, et al. Among authors: schlomm t. Int Urol Nephrol. 2024 Feb;56(2):499-508. doi: 10.1007/s11255-023-03800-0. Epub 2023 Oct 1. Int Urol Nephrol. 2024. PMID: 37777995 Free PMC article.
BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, and CancerCheck® UBC® rapid VISUAL as urinary marker for bladder cancer: Final results of a German multicenter study.
Ecke TH, Meisl CJ, Schlomm T Prof, Rabien A, Labonté F, Rong D, Hofbauer S, Friedersdorff F Prof, Sommerfeldt L, Gagel N, Gössl A, Barski D, Otto T Prof, Grunewald CM, Niegisch G Prof, Hennig MJP, Kramer MW Prof, Koch S Prof, Roggisch J, Hallmann S, Weiß S, Waldner M, Graff J, Veltrup E, Linden F, Hake R, Eidt S, Wirtz RM. Ecke TH, et al. Among authors: schlomm t prof. Urol Oncol. 2023 Dec;41(12):484.e17-484.e26. doi: 10.1016/j.urolonc.2023.06.013. Epub 2023 Jul 4. Urol Oncol. 2023. PMID: 37407421
[Precision oncology options in urological cancers].
Franz A, Plage H, Fendler A, Schlomm T, Kornienko K. Franz A, et al. Among authors: schlomm t. Urologie. 2023 Jul;62(7):696-704. doi: 10.1007/s00120-023-02119-z. Epub 2023 Jun 9. Urologie. 2023. PMID: 37294331 Review. German.
Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder.
Bruch PG, Plage H, Hofbauer S, Kornienko K, Weinberger S, Roßner F, Schallenberg S, Kluth M, Lennartz M, Blessin NC, Marx AH, Samtleben H, Fisch M, Rink M, Slojewski M, Kaczmarek K, Ecke T, Hallmann S, Koch S, Adamini N, Minner S, Simon R, Sauter G, Zecha H, Klatte T, Schlomm T, Horst D, Elezkurtaj S. Bruch PG, et al. Among authors: schlomm t. Exp Mol Pathol. 2023 Jun;131:104860. doi: 10.1016/j.yexmp.2023.104860. Epub 2023 Apr 14. Exp Mol Pathol. 2023. PMID: 36997051 Free article.
398 results